Antifungal Susceptibility Testing: Current Approaches

被引:228
作者
Berkow, Elizabeth L. [1 ]
Lockhart, Shawn R. [1 ]
Ostrosky-Zeichner, Luis [2 ]
机构
[1] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30333 USA
[2] Univ Texas Hlth Sci Ctr Houston, Div Infect Dis, Houston, TX 77030 USA
关键词
antifungal susceptibility testing; CLSI; EUCAST; epidemiological cutoff value; breakpoints; antifungal resistance; IN-VITRO SUSCEPTIBILITY; RESISTANT ASPERGILLUS-FUMIGATUS; CLSI BROTH MICRODILUTION; FLIGHT MASS-SPECTROMETRY; EUCAST TECHNICAL NOTE; DESORPTION IONIZATION-TIME; AMPHOTERICIN-B SUSCEPTIBILITY; INFECTIOUS-DISEASES SOCIETY; NCCLS M38-A METHOD; VITEK; SYSTEM;
D O I
10.1128/CMR.00069-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Although not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility testing (AFST) is a tool of increasing importance in clinical microbiology laboratories. The goal of AFST is to reliably produce MIC values that may be used to guide patient therapy, inform epidemiological studies, and track rates of antifungal drug resistance. There are three methods that have been standardized by standards development organizations: broth dilution, disk diffusion, and azole agar screening for Aspergillus. Other commonly used methods include gradient diffusion and the use of rapid automated instruments. Novel methodologies for susceptibility testing are in development. It is important for laboratories to consider not only the method of testing but also the interpretation (or lack thereof) of in vitro data.
引用
收藏
页数:30
相关论文
共 213 条
[1]  
Al-Hatmi AMS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01671-16, 10.1128/aac.01671-16]
[2]   Comparative evaluation of etest and sensititre YeastOne panels against the clinical and laboratory standards institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents [J].
Alexander, Barbara D. ;
Byrne, Terry C. ;
Smith, Kelly L. ;
Hanson, Kimberly E. ;
Anstrom, Kevin J. ;
Perfect, John R. ;
Reller, L. Barth .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (03) :698-706
[3]   Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations [J].
Alexander, Barbara D. ;
Johnson, Melissa D. ;
Pfeiffer, Christopher D. ;
Jimenez-Ortigosa, Cristina ;
Catania, Jelena ;
Booker, Rachel ;
Castanheira, Mariana ;
Messer, Shawn A. ;
Perlin, David S. ;
Pfaller, Michael A. .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) :1724-1732
[4]   In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods [J].
Alvarado-Ramirez, Eidi ;
Torres-Rodriguez, Josep M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) :2420-2423
[5]  
[Anonymous], CLIN MICROBIOL INFEC
[6]  
[Anonymous], 2009, M44A2 CLSI
[7]   Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates [J].
Arendrup, M ;
Lundgren, B ;
Jensen, IM ;
Hansen, BS ;
Frimodt-Moller, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (05) :521-526
[8]   EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents [J].
Arendrup, M. C. ;
Meletiadis, J. ;
Mouton, J. W. ;
Guinea, J. ;
Cuenca-Estrella, M. ;
Lagrou, K. ;
Howard, S. J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (06) :571.e1-571.e4
[9]   EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole [J].
Arendrup, M. C. ;
Cuenca-Estrella, M. ;
Lass-Floel, C. ;
Hope, W. W. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (07) :E248-E250
[10]   EUCAST technical note on posaconazole [J].
Arendrup, M. C. ;
Cuenca-Estrella, M. ;
Donnelly, J. P. ;
Hope, W. ;
Lass-Floerl, C. ;
Rodriguez-Tudela, J-L .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (11) :E16-E17